Home NDC 76282-256 Raloxifene Hydrochloride
Product NDC 76282-256
11-digit product format 762820256
Labeler code 76282
Product ID 76282-256_7238f870-72f1-4e67-9c88-5125522971da
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Raloxifene Hydrochloride
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Exelan Pharmaceuticals, Inc.
Application ANDA090842
Marketing category ANDA
Marketing start 2014-11-12
Substance RALOXIFENE HYDROCHLORIDE
Active strength 60 mg/1
Pharmacologic classes Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090842-001 RALOXIFENE HYDROCHLORIDE RALOXIFENE HYDROCHLORIDE 60MG TABLET / ORAL AB 2014-09-24
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A090842-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-01 22:54:32 2026-06 A090842-001 RALOXIFENE HYDROCHLORIDE 60MG TABLET / ORAL AB 2014-09-24 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2026-08-01 22:54:32 2026-06 A090842-001 AB 1 a50c72e98297…
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Raloxifene Hydrochloride RALOXIFENE American Health Packaging f5c25553-1546-451d-8069-c0f484c47741 2024-05-13 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090842 application number: ANDA090842 Raloxifene Hydrochloride RALOXIFENE Aphena Pharma Solutions - Tennessee, LLC 53a2db10-4af8-4032-b598-b7c7a0969801 2021-03-17 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090842 application number: ANDA090842 Raloxifene Hydrochloride RALOXIFENE HYDROCHLORIDE Exelan Pharmaceuticals, Inc. 2b94ecf5-d870-4132-b455-d5ee5c9dce56 2020-09-30 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090842 application number: ANDA090842 ndc (product): 76282-256 Raloxifene Hydrochloride RALOXIFENE Cipla USA Inc. 8fef5bfd-a786-4442-b09b-f3b81812cdac 2020-09-07 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 090842 application number: ANDA090842
Additional Listing Data#
Finished product Yes
Brand name base Raloxifene Hydrochloride
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RALOXIFENE HYDROCHLORIDE 60 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 4F86W47BR6 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1490065 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 76282-256-01 Raloxifene Hydrochloride 100 in 1 BOTTLE TABLET, FILM COATED 100 6 76282-256-05 Raloxifene Hydrochloride 500 in 1 BOTTLE TABLET, FILM COATED 500 6 76282-256-10 Raloxifene Hydrochloride 1000 in 1 BOTTLE TABLET, FILM COATED 1000 6 76282-256-30 Raloxifene Hydrochloride 30 in 1 BOTTLE TABLET, FILM COATED 30 6 76282-256-90 Raloxifene Hydrochloride 90 in 1 BOTTLE TABLET, FILM COATED 90 6
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded RALOXIFENE HYDROCHLORIDE ACTIVE INGREDIENT 4F86W47BR6 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 RALOXIFENE ACTIVE MOIETY YX9162EO3I RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 CROSPOVIDONE INACTIVE INGREDIENT 68401960MK RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 HYDROXYPROPYL CELLULOSE INACTIVE INGREDIENT RFW2ET671P RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 HYPROMELLOSE 2910 (3 MPA.S) INACTIVE INGREDIENT 0VUT3PMY82 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 MANNITOL INACTIVE INGREDIENT 3OWL53L36A RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 POLOXAMER 407 INACTIVE INGREDIENT TUF2IVW3M2 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 76282-256 RALOXIFENE HYDROCHLORIDE TABLET, FILM COATED [EXELAN PHARMACEUTICALS, INC.] 6 Current NDC, Legacy NDC, 5 package rows 20201007_2b94ecf5-d870-4132-b455-d5ee5c9dce56.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 76282-256-01 76282025601 100 TABLET, FILM COATED in 1 BOTTLE (76282-256-01) 2014-11-12 0000-00-00 No No Current 76282-256-05 76282025605 500 TABLET, FILM COATED in 1 BOTTLE (76282-256-05) 2014-11-12 0000-00-00 No No Current 76282-256-10 76282025610 1000 TABLET, FILM COATED in 1 BOTTLE (76282-256-10) 2015-04-15 0000-00-00 No No Current 76282-256-30 76282025630 30 TABLET, FILM COATED in 1 BOTTLE (76282-256-30) 2014-11-12 0000-00-00 No No Current 76282-256-90 76282025690 90 TABLET, FILM COATED in 1 BOTTLE (76282-256-90) 2015-04-15 0000-00-00 No No Current